Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
21.05
-0.16 (-0.75%)
Nov 21, 2024, 1:38 PM EST - Market open

KNSA Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Market Capitalization
1,5201,2341,0428111,203607
Upgrade
Market Cap Growth
46.08%18.45%28.46%-32.59%98.17%-56.32%
Upgrade
Enterprise Value
1,3181,046848617840351
Upgrade
Last Close Price
21.2117.5414.9811.7717.6711.06
Upgrade
PE Ratio
-87.605.68---
Upgrade
PS Ratio
3.924.574.7321.04--
Upgrade
PB Ratio
3.502.812.634.383.862.69
Upgrade
P/TBV Ratio
4.232.932.764.893.862.69
Upgrade
P/FCF Ratio
137.2093.67182.67---
Upgrade
P/OCF Ratio
135.4992.76179.37---
Upgrade
EV/Sales Ratio
3.433.873.8516.02--
Upgrade
EV/EBITDA Ratio
--69.62---
Upgrade
EV/EBIT Ratio
--86.73---
Upgrade
EV/FCF Ratio
118.7179.39148.64---
Upgrade
Debt / Equity Ratio
0.020.030.010.030.020.01
Upgrade
Debt / EBITDA Ratio
--0.38---
Upgrade
Debt / FCF Ratio
0.950.931.04---
Upgrade
Asset Turnover
0.740.550.640.13--
Upgrade
Inventory Turnover
5.523.413.72---
Upgrade
Quick Ratio
2.593.584.484.1510.168.39
Upgrade
Current Ratio
3.244.345.164.3810.468.68
Upgrade
Return on Equity (ROE)
-2.15%3.37%63.10%-63.55%-60.06%-64.15%
Upgrade
Return on Assets (ROA)
-3.16%-3.19%1.76%-33.63%-32.57%-36.85%
Upgrade
Return on Capital (ROIC)
-3.79%-3.69%2.06%-38.39%-35.96%-41.88%
Upgrade
Earnings Yield
-0.60%1.14%17.60%-19.48%-13.42%-26.67%
Upgrade
FCF Yield
0.73%1.07%0.55%-15.63%-11.37%-26.62%
Upgrade
Buyback Yield / Dilution
-1.53%-2.13%-2.69%-10.89%-14.42%-82.92%
Upgrade
Total Shareholder Return
-1.53%-2.13%-2.69%-10.89%-14.42%-82.92%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.